Supplement shows promise for leg and brain health in PAD patients
NCT ID NCT06534944
First seen Apr 10, 2026 · Last updated Apr 30, 2026 · Updated 3 times
Summary
This small pilot study looked at whether taking a daily dose of nicotinamide riboside (a form of vitamin B3) for four weeks could improve blood vessel function and thinking skills in older adults with peripheral artery disease (PAD). Eight participants completed the study, and researchers measured changes in blood flow, memory, and attention. The goal was to see if this supplement might help manage the disease and its effects on the brain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
Conditions
Explore the condition pages connected to this study.